Fresenius Medical Care has launched Rephoren for hyperphosphataemia associated with chronic renal impairment in adult patients on dialysis.

Rephoren (calcium acetate and magnesium carbonate) should be taken with meals and swallowed whole to achieve the maximum phosphate binding effect.

The recommended dose is three to 10 tablets daily in divided doses, dependent on the serum phosphate level (maximum 12 tablets daily).

View Rephoren drug record

Further information: Fresenius Medical Care

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Already registered?
Sign in

MIMS Product Slides

Product overviews prepared by the MIMS team, in a handy slide format.

Click here

Slides are initiated, funded & reviewed by the companies specified.

Register or Subscribe to MIMS

GPs can get MIMS print & online and GPonline for free when they register online – take 2 minutes, and make sure you get your free MIMS access! If you're not a GP, you can subscribe to MIMS for full access.

Register or subscribe

MIMS Dermatology

Read the latest issue online exclusively on MIMS Learning.

Read MIMS Dermatology

MIMS Adviser

Especially created for prescribing influencers.

Request free copy

Mobile apps

MIMS: access the full drug database and quick-reference tables on the go

MIMS Diagnosis and Management: concise information on signs and symptoms, investigations and diseases